Skip to Main Content

Paper Details

Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma.
Nucleic Acids Res
1
2023
Enhancer, FOXA1, NFIB, SOX2, SOX2 oncogene, SRR124, SRR124 and, SRR124-134, SRR124-134 cluster, SRR134, SRR134 regions, Sox2, breast and lung adenocarcinoma, breast and lung cancer, breast and lung cancer cells, breast and lung tumors, cancer, cancer cells, chromatin, developmental enhancers, distal developmental enhancer cluster, distal enhancers, enhancer cluster, enhancers, failure of esophageal-tracheal separation, mouse, patients, tumor, tumors
Author NameAffiliation
Michael M HoffmanPrincess Margaret Cancer Centre, University Health Network
Michael M HoffmanUniversity of Toronto
Michael M HoffmanUniversity of Toronto
Michael M HoffmanVector Institute for Artificial Intelligence
Michael M HoffmanPrincess Margaret Cancer Centre, University Health Network
Michael M HoffmanUniversity of Toronto
Michael M HoffmanUniversity of Toronto
Michael M HoffmanVector Institute for Artificial Intelligence
  • 1 - 8

Datasets

Release 1.2